Annual CFF
$27.52 M
+$28.51 M+2897.05%
December 31, 2022
Summary
- As of February 10, 2025, FRLN annual cash flow from financing activities is $27.52 million, with the most recent change of +$28.51 million (+2897.05%) on December 31, 2022.
- During the last 3 years, FRLN annual CFF has fallen by -$87.07 million (-75.98%).
Performance
FRLN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$0.00
-$32.00 K-100.00%
September 1, 2023
Summary
- As of February 10, 2025, FRLN quarterly cash flow from financing activities is $0.00, with the most recent change of -$32.00 thousand (-100.00%) on September 1, 2023.
- Over the past year, FRLN quarterly CFF has increased by +$3000.00 (+100.00%).
Performance
FRLN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$120.00 K
+$3000.00+2.56%
September 1, 2023
Summary
- As of February 10, 2025, FRLN TTM cash flow from financing activities is $120.00 thousand, with the most recent change of +$3000.00 (+2.56%) on September 1, 2023.
- Over the past year, FRLN TTM CFF has dropped by -$26.23 million (-99.54%).
Performance
FRLN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
FRLN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2897.1% | +100.0% | -99.5% |
| 3 y3 years | -76.0% | -100.0% | -100.0% |
| 5 y5 years | -27.8% | - | - |
FRLN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -103.6% | -100.0% | <-9999.0% | -99.6% | -920.0% |
| 5 y | 5-year | -88.7% | -103.6% | -100.0% | <-9999.0% | -100.0% | -920.0% |
| alltime | all time | -88.7% | -103.6% | -100.0% | <-9999.0% | -100.0% | -920.0% |
Freeline Therapeutics Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $0.00(-100.0%) | $120.00 K(+2.6%) |
| Jun 2023 | - | $32.00 K(>+9900.0%) | $117.00 K(-94.9%) |
| Mar 2023 | - | $0.00(-100.0%) | $2.28 M(-91.7%) |
| Dec 2022 | $27.52 M(-2897.1%) | $88.00 K(-3033.3%) | $27.52 M(+4.5%) |
| Sep 2022 | - | -$3000.00(-100.1%) | $26.35 M(-0.0%) |
| Jun 2022 | - | $2.19 M(-91.3%) | $26.35 M(+8.6%) |
| Mar 2022 | - | $25.25 M(-2420.3%) | $24.26 M(-2565.5%) |
| Dec 2021 | -$984.00 K | - | - |
| Dec 2021 | - | -$1.09 M(>+9900.0%) | -$984.00 K(-478.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$1000.00(-101.0%) | $260.00 K(-99.9%) |
| Jun 2021 | - | $105.00 K(>+9900.0%) | $174.87 M(-27.6%) |
| Mar 2021 | - | $0.00(-100.0%) | $241.44 M(-0.5%) |
| Dec 2020 | $242.62 M(+111.7%) | - | - |
| Dec 2020 | - | $156.00 K(-99.9%) | $242.62 M(+0.1%) |
| Sep 2020 | - | $174.60 M(+161.9%) | $242.46 M(+257.3%) |
| Jun 2020 | - | $66.68 M(+5536.3%) | $67.86 M(+5636.3%) |
| Mar 2020 | - | $1.18 M | $1.18 M |
| Dec 2019 | $114.59 M(+200.5%) | - | - |
| Dec 2018 | $38.13 M | - | - |
FAQ
- What is Freeline Therapeutics Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings annual CFF year-on-year change?
- What is Freeline Therapeutics Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings quarterly CFF year-on-year change?
- What is Freeline Therapeutics Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings TTM CFF year-on-year change?
What is Freeline Therapeutics Holdings annual cash flow from financing activities?
The current annual CFF of FRLN is $27.52 M
What is the all time high annual CFF for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high annual cash flow from financing activities is $242.62 M
What is Freeline Therapeutics Holdings annual CFF year-on-year change?
Over the past year, FRLN annual cash flow from financing activities has changed by +$28.51 M (+2897.05%)
What is Freeline Therapeutics Holdings quarterly cash flow from financing activities?
The current quarterly CFF of FRLN is $0.00
What is the all time high quarterly CFF for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high quarterly cash flow from financing activities is $174.60 M
What is Freeline Therapeutics Holdings quarterly CFF year-on-year change?
Over the past year, FRLN quarterly cash flow from financing activities has changed by +$3000.00 (+100.00%)
What is Freeline Therapeutics Holdings TTM cash flow from financing activities?
The current TTM CFF of FRLN is $120.00 K
What is the all time high TTM CFF for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high TTM cash flow from financing activities is $242.62 M
What is Freeline Therapeutics Holdings TTM CFF year-on-year change?
Over the past year, FRLN TTM cash flow from financing activities has changed by -$26.23 M (-99.54%)